ChemCatBio is a U.S. Department of Energy national lab-led research and development consortium dedicated to identifying and overcoming catalysis challenges for the conversion of biomass and waste resources into fuels, chemicals, and materials.
By leveraging unique lab capabilities and public-private partnerships, we seek to accelerate the catalyst-process development cycle, resulting in rapid transition of research and development (R&D) discoveries and growth of the bioeconomy in the United States.
Learn more about our existing R&D projects and partnerships.
News
ChemCatBio recently released its catalyst cost estimating tool to the public, incorporating industry standard estimation methods into a user-friendly spreadsheet and web tool. Try CatCost today!
Miss a ChemCatBio webinar? Recordings of all webinars are available to view online at any time. Get more information about future presentations and get caught up in the previous webinars that discuss existing ChemCatBio R&D projects and public-private partnerships.
Work with Us to Solve Your Catalysis Challenges
Contact UsVarious mechanisms exist to leverage our unique capabilities and expertise through public-private partnerships. Contact us today to find out how.
Cooperative Research and Development Agreements (CRADA)
For collaborative projects, CRADAs protect existing intellectual property and allow your company to negotiate for exclusive field-of-use licenses.
Funds-In Agreement (FIA)
Used with strategic partnership projects, a nonfederal entity pays to conduct a research-oriented project; includes intellectual property provisions.
Agreements for Commercializing Technology (ACT)
For partners seeking highly specialized or technical services to complete a project, ACT provides flexible terms.
Technical Services Agreement (TSA)
TSAs work well for projects $500,000 or less and up to three years in duration; they are funded entirely by the sponsor for services.
Funding Opportunity Announcement (FOA)
These discretionary grants or cooperative agreements are the result of a competition for funds.
ChemCatBio provides streamlined access to intellectual property. All participants of ChemCatBio have collectively negotiated CRADA and Intellectual Property (IP) Management Plan templates. These agreements allow industry to partner with the national labs and easily access IP that results from those engagements. Under the CRADA, IP ownership follows inventorship, with the industrial partner having a right to negotiate an exclusive license to IP developed with the ChemCatBio consortium.
R&D Advancements
Recent ChemCatBio research offers new perspectives on catalytic fast pyrolysis.
